Key Takeaways
- Monoplace: single-patient chamber pressurised with 100% medical oxygen; patient breathes chamber environment directly.
- Multiplace: large steel vessel pressurised with air; multiple patients breathe oxygen via mask or hood with an in-chamber attendant.
- At the same pressure, monoplace and multiplace deliver clinically equivalent HBOT — choice is driven by workflow, acuity, and cost.
- Monoplace capital cost: $150K–$300K per unit. Multiplace: $500K–$2M+ plus substantial facility costs.
- Multiplace is preferred for critical-care patients, decompression emergencies, and high-throughput wound-care programmes. Monoplace is the dominant US configuration for routine clinical and neurological HBOT.
The Core Difference
A monoplace chamber is a single-patient unit pressurised with 100% oxygen. The patient lies inside a transparent cylindrical shell and breathes the chamber atmosphere directly. A multiplace chamber is a large steel vessel treating multiple patients at once; the chamber itself is pressurised with air, and patients breathe 100% oxygen through masks or hoods. Medical staff can be inside the chamber during treatment in a multiplace design.
Clinical Equivalence
At the same treatment pressure (e.g. 2.4 ATA) and session length, monoplace and multiplace deliver clinically equivalent HBOT. The physiological effect — elevated arterial oxygen tension, downstream angiogenesis and HIF-1α signalling — depends on pressure and inspired oxygen fraction, not chamber configuration.
When Multiplace Is Preferred
- Critical care HBOT — ventilated or ICU-level patients need an attending clinician inside the chamber.
- Decompression emergencies — US Navy Treatment Tables 6 and 6A are typically run in multiplace units.
- High-throughput wound-care programmes — treating 4–6 patients per session is logistically efficient.
- Claustrophobic patients — multiplace feels more like a small room than a tube.
When Monoplace Is Preferred
- Smaller clinical programmes — the capital cost ($150–300K) is one-tenth to one-fifth of a multiplace unit.
- Simpler staffing — one technician can supervise a bank of monoplace chambers without needing an in-chamber attendant.
- Infection control — single-patient isolation.
- Dedicated neurological HBOT clinics — most 2.0 ATA neurological programmes use monoplace.
Patient Experience
Monoplace: patients lie supine in a transparent cylinder; they can watch TV, listen to audio, or sleep. The experience is enclosed but visually open. Multiplace: patients sit upright in a small room-like space wearing a hood or mask; movement is possible but limited by the breathing apparatus.
Cost at the Facility Level
- Monoplace: $150,000–$300,000 per chamber. Minimal supporting infrastructure.
- Multiplace: $500,000–$2,000,000+ for the chamber, plus substantial facility costs (reinforced structure, dedicated gas delivery systems, trained chamber operators).
Choosing Between Them
For most elective HBOT — wound care, neurological protocols, veterinary applications, and research — monoplace is adequate and preferred for cost reasons. Multiplace is appropriate for high-acuity, high-volume, or emergency-response programmes.
Frequently Asked Questions
Which is safer, monoplace or multiplace?
Both have excellent safety profiles. Multiplace offers in-chamber clinical response but introduces attendant decompression sickness risk. The choice is driven by clinical needs, not safety.
Is monoplace more claustrophobic?
A minority of patients find the transparent monoplace shell confining. Multiplace feels more like a small room. Options for severe claustrophobia include anxiolysis or choosing multiplace treatment.
Can I move around in a multiplace chamber?
Yes, within limits. Patients can sit upright and move around the chamber interior, but movement is restricted by the breathing hood or mask connected to the overboard oxygen system.
Which is better for TBI or long COVID?
Clinical outcome at a given pressure is equivalent between configurations. Most neurological HBOT in the US is delivered in monoplace chambers for cost reasons; some research centres use multiplace.
